234 related articles for article (PubMed ID: 33636206)
41. Different characteristics of hepatoid and non-hepatoid alpha-fetoprotein-producing gastric carcinomas: an experimental study using xenografted tumors.
Aizawa K; Motoyama T; Suzuki S; Tanaka N; Yabusaki H; Tanaka S; Muto I; Tanaka O; Hatakeyama K
Int J Cancer; 1994 Aug; 58(3):430-5. PubMed ID: 7519587
[TBL] [Abstract][Full Text] [Related]
42. Esophageal adenocarcinoma with enteroblastic differentiation arising in ectopic gastric mucosa in the cervical esophagus: a case report and literature review.
Gushima R; Narita R; Shono T; Naoe H; Yao T; Sasaki Y
J Gastrointestin Liver Dis; 2017 Jun; 26(2):193-197. PubMed ID: 28617891
[TBL] [Abstract][Full Text] [Related]
43. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis.
Nagai E; Ueyama T; Yao T; Tsuneyoshi M
Cancer; 1993 Sep; 72(6):1827-35. PubMed ID: 7689918
[TBL] [Abstract][Full Text] [Related]
44. [Clinicopathologic characteristics and prognosis of gastric hepatoid adenocarcinoma].
Zhao R; Wang X; Lan X; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1035-1039. PubMed ID: 28900996
[TBL] [Abstract][Full Text] [Related]
45. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
Liu X; Sheng W; Wang Y
J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
[TBL] [Abstract][Full Text] [Related]
46. Ampullary Carcinosarcoma with Enteroblastic Differentiation: A Case Report.
Haider MA; Naqvi S; Barakat O; Wilken SE; Dhingra S
Ann Clin Lab Sci; 2021 Jan; 51(1):131-135. PubMed ID: 33653792
[TBL] [Abstract][Full Text] [Related]
47. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.
Gao YB; Zhang DF; Jin XL; Xiao JC
J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131
[TBL] [Abstract][Full Text] [Related]
48. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
Yatagai N; Saito T; Akazawa Y; Hayashi T; Yanai Y; Tsuyama S; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
Virchows Arch; 2019 Mar; 474(3):315-324. PubMed ID: 30554333
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases.
Yang X; Wu Y; Wang A; Ma X; Zhou K; Ji K; Ji X; Zhang J; Wu X; Li Z; Bu Z
J Pathol Clin Res; 2024 Jan; 10(1):e343. PubMed ID: 37974386
[TBL] [Abstract][Full Text] [Related]
50. Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a Case.
Nuevo-Gonzalez JA; Cano-Ballesteros JC; Lopez B; Andueza-Lillo JA; Audibert L
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S28-31. PubMed ID: 21826411
[TBL] [Abstract][Full Text] [Related]
51. Carcinosarcoma of the stomach: four cases that expand the morphologic spectrum of gastric cancer with a primitive phenotype.
Yamazawa S; Ushiku T
Virchows Arch; 2022 May; 480(5):1051-1062. PubMed ID: 35243539
[TBL] [Abstract][Full Text] [Related]
52. Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature.
Haninger DM; Kloecker GH; Bousamra Ii M; Nowacki MR; Slone SP
Mod Pathol; 2014 Apr; 27(4):535-42. PubMed ID: 24030743
[TBL] [Abstract][Full Text] [Related]
53. Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma).
Roberts CC; Colby TV; Batts KP
Mayo Clin Proc; 1997 Dec; 72(12):1154-60. PubMed ID: 9413299
[TBL] [Abstract][Full Text] [Related]
54. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study.
Li L; Yang X; Ji W; Zhu Q; Yang X; Niu J; Li W
BMC Gastroenterol; 2023 May; 23(1):142. PubMed ID: 37161409
[TBL] [Abstract][Full Text] [Related]
55. [AFP-producing gastric cancer and hepatoid gastric cancer].
Wang YK; Zhang XT
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):801-807. PubMed ID: 29151285
[TBL] [Abstract][Full Text] [Related]
56. Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
Li M; Mei YX; Wen JH; Jiao YR; Pan QR; Kong XX; Li J
Cancer Lett; 2023 Apr; 559():216104. PubMed ID: 36863507
[TBL] [Abstract][Full Text] [Related]
57. Hepatoid adenocarcinoma of the stomach.
Inagawa S; Shimazaki J; Hori M; Yoshimi F; Adachi S; Kawamoto T; Fukao K; Itabashi M
Gastric Cancer; 2001; 4(1):43-52. PubMed ID: 11706627
[TBL] [Abstract][Full Text] [Related]
58. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
Hishinuma M; Ohashi KI; Yamauchi N; Kashima T; Uozaki H; Ota S; Kodama T; Aburatani H; Fukayama M
Histopathology; 2006 Nov; 49(5):479-86. PubMed ID: 17064293
[TBL] [Abstract][Full Text] [Related]
59. Arginase-1 is frequently positive in hepatoid adenocarcinomas.
Chandan VS; Shah SS; Torbenson MS; Wu TT
Hum Pathol; 2016 Sep; 55():11-6. PubMed ID: 27137985
[TBL] [Abstract][Full Text] [Related]
60. Histogenesis of hepatoid adenocarcinoma of the stomach: molecular evidence of identical origin with coexistent tubular adenocarcinoma.
Akiyama S; Tamura G; Endoh Y; Fukushima N; Ichihara Y; Aizawa K; Kawata S; Motoyama T
Int J Cancer; 2003 Sep; 106(4):510-515. PubMed ID: 12845645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]